AGIOS PHARMACEUTICALS, INC. ($AGIO)
Filing Information
| Accession Number | 0001439222-26-000049 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 9, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
19,159
Total Value
$82,260.20
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Corp Dev & Strategy | Common stock | โ | Mar 5, 2026 | Exercise/Conversion | 8,100 | $0.00 | $0.00 | 8,100 | Direct | โ | View Details | |
Chief Corp Dev & Strategy | Common stock | โ | Mar 5, 2026 | Sale | 2,959 | $27.80 | $82,260.20 | 5,141 | Direct | โ | View Details | |
Chief Corp Dev & Strategy | Restricted stock units | Derivative | Mar 5, 2026 | Exercise/Conversion | 8,100 | $0.00 | $0.00 | 16,200 | Direct | โ | View Details |